Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Biologic therapy. National Cancer Center Hospital, Tokyo, Japan



Survival: 13.9 months
   
Toxicity Grade: 3
   
Treatments: Biologic therapy
   
Drugs:
Country: Japan
   
City/State/Province: Tokyo
   
Hospital: National Cancer Center Hospital
   
Journal: Link
   
Date: 7/2015

Description:
Patients:
This phase 1/2 study involved 11 melanoma patients who had the BRAFV600 mutation. The median patient age was 49 years and 3 were male.

Treatment:
Patients received biologic therapy with vemurafenib, a kinase inhibitor that interferes with cancer cell growth.

Toxicities:
The most severe toxicities were of grade 3 and included rash and liver toxicity. Grade 2 fever, headache, and fatigue were also reported.

Results:
The median overall survival was 13.9 months.

Support:
This study was supported by Chugai Pharmaceutical.

Correspondence: Dr. Naoya Yamazaki; email: nyamazak@ncc.go.jp

E-mail to a Friend Email Physician More Information